ABASAGLAR 100U/ML INJ SOL ZVL 10X3ML

What is the maximum co-payment for ABASAGLAR?

If the insurance company contributes, the maximum co-payment is 187,96 Kč. The maximum pharmacy price is 2 282,66 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but check the specialization of the prescribing physician below (a so-called non-delegable prescription).

Does ABASAGLAR have a counted co-payment set?

Yes, the medicine has a counted co-payment of 409,00 Kč. Learn more about the protective limit here.

How much does the insurance company pay for one dispensed reimbursed pack?

2 094,70 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

Analoga inzulinu s dlouhodobým účinkem jsou hrazena u pacientů s diabetes mellitus 1. i 2. typu tehdy, jestliže stávající léčbou není dosaženo cílových hodnot kompenzace (glykovaný hemoglobin HbA1c pod 60 mmol/mol), nebo jestliže pacient léčený humánními inzuliny má opakovaně těžké hypoglykemie. Pokud nedojde do 3 měsíců k prokazatelnému zlepšení kompenzace diabetu (pokles HbA1c alespoň o 10 %, nebo významnému snížení incidence hypoglykemií), léčba analogy inzulinu s dlouhodobým účinkem není nadále hrazena.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe ABASAGLAR?

diabetology
endocrinology
internal medicine

What is the composition of ABASAGLAR?

Insulin-glargin (3,64 mg), oxid zinečnatý, metakresol, glycerol, kyselina chlorovodíková, solution hydroxidu sodného, voda pro injekci (1 ml). More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to ABASAGLAR?

The medicine belongs to ATC group A10AE04 – INSULIN GLARGIN. Medicines with the same active substance can be found here.

Who manufactures ABASAGLAR?

Eli Lilly Nederland B.V., Utrecht (NL)

Is the medicine in shortage?

The latest report from the manufacturer is from 30. 7. 2024. Production was terminated with effect from 30. 9. 2024. The manufacturer lists medicines with the following code as a potential substitute:

Note provided: Lék obtížně nahraditelný (převedení pacienta na jiný typ, sílu nebo značku inzulinu musí být vždy provedeno pod lékařským dohledem).